These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2006-004759-39 Doppelblinde, randomisierte klinische Studie zum Vergleich der Wirksamkeit und Verträglichkeit einer Nystatin (100 000 I.E./g)/Hydrocortisonacetat (5 mg/g) -haltigen Paste vs. einer Nystatin (100 000 ... 2010-03-03 due-trials
Reported results 2008-004695-49 Doppelblinde, randomisierte klinische Studie zum Vergleich der Wirksamkeit und Verträglichkeit von Terbinafin Creme 1% vs. Lamisil® Creme vs. Grundlage bei Patienten mit Tinea pedis 2010-04-16 due-trials
Reported results 2010-024033-24 Doppelblinde, randomisierte klinische Studie zum Vergleich der Wirksamkeit und Verträglichkeit von Betamethason 0,05%_Salicylsäure 2% Lösung vs. Diprosalic Lösung vs. Grundlage bei Patienten mit Psori... 2013-10-15 due-trials
Reported results 2011-003317-41 Double-blind, randomized, clinical trial to compare the efficacy and safety of diclofenc 3% gel vs. Solaraze 3% gel vs. vehicle for the treatment of patients with actinic keratosis. Doppelblinde, r... 2013-03-22 due-trials
Reported results 2011-004370-28 Double-blind, randomized clinical trial to compare the efficacy and safety of fusidic acid 2% betamethasone 0,1% cream vs. Fucicort cream vs. vehicle for patients with bacterial infected eczemas. ... 2014-08-22 due-trials
Completed, but no date, and reported results 2013-000371-32 Randomised, double-blind, vehicle controlled trial comparing Amphotericin B 100.000 I.E./g oral gel vs. Ampho-Moronal® suspension vs. modified vehicle to suspension in adult patients with oropharyngea... bad-data
Reported results Terminated 2013-000654-22 Randomised, double-blind, double-dummy, vehicle controlled parallel trial comparing a novel mometasone furoate nasal spray vs. Nasonex® nasal spray vs. vehicle nasal spray in patients with allergic rh... 2015-02-26 due-trials
Reported results 2014-001621-33 Multicenter, randomised, double-blind clinical trial on the efficacy and safety of medicinal products containing Diclofenac in patients with actinic keratosis Multizentrische, randomisierte, doppel... 2015-06-26 due-trials
Reported results 2014-005518-44 Double-blind, randomised clinical study comparing efficacy and safety of Gentamicin 0.1%_Betamethasone 0.05% Cream (Test) vs. Diprogenta(R) Cream (Reference) vs. Vehicle in patients with bacterial inf... 2017-01-11 due-trials
Reported results 2014-005519-18 Double-blind, randomised clinical study comparing efficacy and safety of Gentamicin 0.1%_Betamethasone 0.05% Ointment (Test) vs. Diprogenta(R) Ointment (Reference) vs. Vehicle in patients with bacteri... 2017-06-09 due-trials
Completed, but no date, and reported results 2015-005707-92 Double-blind, randomised clinical study comparing efficacy and safety of Miconazole 2% Fluprednidene 0.1% Cream (Test) vs. Vobaderm® Cream (Reference) vs. Vehicle in patients with moderate to severely... bad-data
Reported results 2016-000712-15 Double-blind, randomised clinical study comparing efficacy and safety of Imiquimod 5% Cream (Test) vs. Aldara® 5% Cream (Reference) vs. Vehicle in patients with actinic keratosis 2019-01-18 due-trials
Completed, but no date, and reported results 2016-001106-42 Double-blind, randomised clinical study comparing efficacy and safety of Calcipotriol 50 µg/g_Betamethasone 0.5 mg/g Gel (Test) vs. Daivobet(R) Gel (Reference) vs. Vehicle in patients with scalp psori... bad-data
Reported results 2016-001568-12 A multi-centre, randomised, double-blind, parallel-group phase III study to investigate the efficacy, safety, and tolerability of a generic calcipotriol-betamethasone ointment formulation compared to ... 2017-05-31 due-trials
Reported results 2017-000521-13 Double-blind, randomised clinical study comparing efficacy and safety of Clindamycin/Benzoyl Peroxide Gel (10 mg/g + 30 mg/g) (Test) vs. DUAC®10 mg/g + 30 mg/g Gel (Reference) vs. Vehicle in patients ... 2021-03-01 due-trials
Reported results 2017-000522-36 Double-blind, randomised clinical study comparing efficacy and safety of Clindamycin/Benzoyl Peroxide Gel (10 mg/g + 50 mg/g) (Test) vs. DUAC(R) Akne Gel (Reference) vs. Vehicle in patients with papul... 2021-06-02 due-trials
Reported results 2018-001633-41 Double-blind, randomised clinical study comparing efficacy and safety of Ciclopirox Olamine Cream 10 mg/g (Test) vs. Batrafen® Cream (Reference) vs. Vehicle in patients with skin mycoses Doppelblin... 2021-06-08 due-trials
Completed, but no date, and reported results Terminated 2018-001743-31 Double-blind, randomised clinical study comparing efficacy and safety of Methylprednisolone Aceponate 0.1% Cutaneous emulsion (Test) vs. Advantan Milk 0.1% Cutaneous emulsion (Reference) vs. Vehicle i... bad-data
Not reported 2019-001010-42 Double-blind, randomised clinical study comparing efficacy and safety of Miconazole 2%_Fluprednidene 0.1% Cream (Test) vs. Vobaderm® Cream (Reference) vs. Vehicle in patients with moderate to severely... 2023-08-29 due-trials
Ongoing 2019-002686-35 Double-blind, randomised clinical study comparing efficacy and safety of Methylprednisolone Aceponate 0.1% Ointment (Test) vs. Advantan 0.1% Ointment (Reference) vs. Vehicle in patients with mild to m... not-yet-due
Other 2020-004081-19 Double-blind, randomised clinical study comparing efficacy and safety of Betamethasone dipropionate 0.64 mg/g _ Salicylic acid 30 mg/g Ointment (Test) vs. Diprosalic(R) Ointment (Reference) vs. Vehicl... not-yet-due
Other 2021-003790-65 Double-blind, randomised clinical study comparing efficacy and safety of Mecloderm® Ointment (Test) vs. Lotricomb® Ointment (Reference) vs. Vehicle in patients with moderate to severely inflamed candi... not-yet-due
No trial status on register 2022-002644-48 Double-blind, randomised clinical study comparing efficacy and safety of Methylprednisolone Aceponate 0.1% Cream (Test) vs. Advantan(R) 0.1% Cream (Reference) vs. Vehicle in patients with mild to mode... bad-data